Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group

Epilepsy in high-grade glioma patients is a major concern, mainly as regards indications to treatment and best choice; toxicities, and pharmocokinetic and pharmacodynamic interactions of drugs. All these generally unsolved problems complicate patients' quality of life and interfere with the eva...

Full description

Saved in:
Bibliographic Details
Published inNeurological sciences Vol. 27; no. 5; pp. 345 - 351
Main Authors Riva, M, Salmaggi, A, Marchioni, E, Silvani, A, Tomei, G, Lorusso, L, Merli, R, Imbesi, F, Russo, A
Format Journal Article
LanguageEnglish
Published Italy Springer Nature B.V 01.11.2006
Subjects
Adult
Aged
Brain Neoplasms
Combined Modality Therapy - methods
Demography
Epilepsy - complications
Epilepsy - epidemiology
Epilepsy - mortality
Epilepsy - therapy
Female
Glioblastoma - complications
Glioblastoma - epidemiology
Glioblastoma - mortality
Glioblastoma - therapy
Humans
Male
Middle Aged
Neurology
Neurosciences
Proportional Hazards Models
Prospective Studies
Quality of Life
Retrospective Studies
Online AccessGet full text

Cover

More Information
Summary:Epilepsy in high-grade glioma patients is a major concern, mainly as regards indications to treatment and best choice; toxicities, and pharmocokinetic and pharmacodynamic interactions of drugs. All these generally unsolved problems complicate patients' quality of life and interfere with the evaluation of response criteria in clinical trials. A prospective, multicentre data collection on 132 adult newly diagnosed, histologically proven glioblastomas from 9 Lombardy hospitals collected in the same database during a one-year period was recently published. From this database we report epidemiological and clinical characteristics in epilepsy-symptomatic (31%) glioblastoma patients vs. the group with other presenting symptoms (69%). We analyse demographic and clinico-radiological features, timing of onset and the course of seizures, and modalities of treatment in the two groups of patients. No statistically significant differences were observed between the two groups as regards age, site of lesion(s), extent of surgery and survival in relation to anticonvulsant treatment status or pharmacokinetic properties of drugs.
ISSN:1590-1874
1590-3478
DOI:10.1007/s10072-006-0708-6